The regulatory landscape is quickly evolving and is more cumbersome than ever before. Advancements in both drug development and regulatory tools make it increasingly hard to predict how regulatory agencies will view new medicines. Meanwhile, increased transparency means that there is a plethora of information available. We're here to help.
Every day, companies are faced with a challenging volume of global regulatory information, clinical trial data, and policies that impact drug development strategies.
Our regulatory intelligence services provide a fast and easy way to stay informed in a complex and rapidly changing regulatory environment.
how do you Stay on top?
Our services include customized daily monitoring of FDA and EMA activity, delivered to your inbox, including but not limited to:
Drug and biologics approvals and withdrawals
Companion diagnostics approvals
Industry policies and periodic regulatory updates
Proceedings from FDA-sponsored workshops and advisory committee meetings
EMA/CHMP meeting highlights
Based on your specific interests, we provide brief, high-level summaries of critical FDA and EMA activity so that your company can stay informed and up-to-date with minimal time and effort.
Need a deeper dive? We can do that too – contact us.